BIOA vs CUBE · rev $9.0M vs P/E 25, rev $1.07B
BioAge Labs, Inc (BIOA) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
BIOA currently screens at market cap $697.9M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the BIOA and CUBE stock pages for the full models.
Not investment advice.